Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 17,788 | 16,608 | 49,593 | 8,279 | 10,712 |
| Gross Profit | 17,788 | 16,608 | 49,593 | 8,279 | 10,712 |
| Operating Expenses | 32,683 | 32,746 | 52,386 | 45,658 | 36,430 |
| Operating Income | -14,895 | -16,138 | -2,793 | -37,379 | -25,718 |
| Other Income | 185 | 459 | 1,087 | 1,503 | 2,019 |
| Pre-tax Income | -14,710 | -15,679 | -1,706 | -35,876 | -23,699 |
| Income Tax | N/A | N/A | -13,911 | -421 | N/A |
| Net Income Continuous | -14,710 | -15,679 | 12,205 | -35,455 | -23,699 |
| Net Income | $-14,710 | $-15,679 | $12,205 | $-35,455 | $-23,699 |
| EPS Basic Total Ops | -0.32 | -0.34 | 0.27 | -0.79 | -0.52 |
| EPS Basic Continuous Ops | -0.32 | -0.34 | 0.27 | -0.78 | -0.52 |
| EPS Diluted Total Ops | -0.32 | -0.34 | 0.26 | -0.79 | -0.52 |
| EPS Diluted Continuous Ops | -0.32 | -0.34 | 0.26 | -0.78 | -0.52 |
| EBITDA(a) | $-14,270 | $-15,703 | $-2,283 | $-37,036 | $-25,597 |